Accelerate progress at the forefront of gene therapy by driving the commercial launch of novel in vivo CRISPR treatments in the South. Develop strategic relationships and communicate key scientific data to healthcare professionals in a competitive market.

Innovate the landscape of genetic therapies by leading the launch of a pioneering in vivo CRISPR treatment for hereditary angioedema, engaging healthcare providers, and managing complex stakeholders in a competitive rare disease market.

Lead the charge in market access strategy development to facilitate the successful adoption and launch of innovative gene editing therapies. Collaborate cross-functionally to create compelling value narratives targeting diverse stakeholders and support global market readiness.

Lead the commercialization of a groundbreaking in vivo CRISPR therapy by developing relationships with key healthcare providers and managing complex sales pipelines within a highly competitive rare disease market.

Accelerate your career by managing the launch of innovative in vivo CRISPR therapies. Utilize advanced scientific communication and stakeholder engagement to drive success in a competitive rare disease market, focusing on key accounts and provider education.